CAPRICOR DEVELOPS FIRST-IN-CLASS THERAPEUTICS
FOR THE TREATMENT OF DISEASES
ALLSTAR (ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration) is a clinical trial for people who have experienced a heart attack within the last year.
Physicians Click here for more information
The Halt cardiomyOPathy progrEssion in Duchenne (HOPE) Phase I/I trial will evaluate CAP-1002 in patients with Duchenne Muscular Dystrophy associated cardiomyopathy.
Click here for more information
SocialTweets by @Capricor_News